Vermillion, Inc. has been invited to present at Leerink Partners' Global Healthcare Conference. The conference will be held at the Waldorf Astoria Hotel in New York City from February 12-13, 2014.
President and CEO of Vermillion, Thomas McLain, is scheduled to present on Thursday, February 13, 2014 at 3:05 p.m. Eastern time.
He will be joined by Eric Schoen, the company's vice president of finance and chief accounting officer, for one-on-one meetings to be held throughout the day.
Management will discuss the company's initiatives to drive market adoption of OVA1®, as well as plans to expand its patient base and launch a next-generation diagnostic test.